Hence it is the first time that such an impressive number of research funders and policy-makers have identified and published a consensus view on the research and development needed in order to further advance personalised medicine.
The Action Plan lists, 22 research and 8 supporting activities, which have been identified as ‘ready for action’. These span the whole healthcare value chain, from basic to clinical research until market access, and also take into account patient empowerment and sustainability of healthcare systems. ICPerMed regards this Action Plan as a blueprint for a coordinated approach for personalised medicine research and the reasonable implementation of innovative and promising approaches in the health systems.
Further information and a full list of ICPerMed members are available on the webpage: www.ICPerMed.eu
For inquiries, please contact the ICPerMed Secretariat (coordinated by DLR):
The DLR Project Management Agency specialises in services for the funding of research, innovation and education. As one of Germany’s largest project management agencies, it supports German state and federal ministries in implementing research funding programmes and operates on behalf of the European Commission, foundations and associations.